Iris Dorbian
Minneapolis-based Upsie, a consumer warranty startup, has raised $5 million in funding. True Ventures led the round.
SoFi, a personal finance company, has secured over $500 million in funding. Qatar Investment Authority was the lead investor.
SoFi, a personal finance company, has secured over $500 million in funding. Qatar Investment Authority was the lead investor.
Bedrock Capital is seeking to raise $15 million for its second entrepreneurs fund, according to an SEC filing. The New York City-based early-stage venture firm was co-founded by Geoff Lewis, formerly of Founders Fund and Eric Stromberg, formerly of Google.
Munich-based Twaice, a provider of predictive battery analytics software, has increased its seed financing to 3.2 million euros. The investors were Cherry Ventures, UVC Partners and Speedinvest.
Betterview, a real estate platform, has secured $4.5 million in Series A funding. ManchesterStory led the round with participation from Nationwide Ventures, EMC Insurance, Maiden Re and Compound. In conjunction with the funding, Betterview has added Dave Miles, a managing partner of ManchesterStory and Brian Desmond, CMO of Guidewire Software, to its board of directors.
Betterview, a real estate platform, has secured $4.5 million in Series A funding. ManchesterStory led the round with participation from Nationwide Ventures, EMC Insurance, Maiden Re and Compound. In conjunction with the funding, Betterview has added Dave Miles, a managing partner of ManchesterStory and Brian Desmond, CMO of Guidewire Software, to its board of directors.
Tel Aviv-based Identiq, a provider of an anonymous verification network, has secured $50 million in seed funding. Entrée Capital led the round with participation from other investors that included Slow Ventures, Vertex Ventures Israel and Oryzn Capital.
Wilmington, Delaware and Israel-based Ayala Pharmaceuticals Inc, a clinical-stage company developing medicines for cancers that are genetically defined, has raised $30 million in Series B financing. Novartis led the round with participation from other investors that included SBI JI Innovation Fund, Israel Biotech Fund, aMoon and Harel Insurance & Finance Group.
Wilmington, Delaware and Israel-based Ayala Pharmaceuticals Inc, a clinical-stage company developing medicines for cancers that are genetically defined, has raised $30 million in Series B financing. Novartis led the round with participation from other investors that included SBI JI Innovation Fund, Israel Biotech Fund, aMoon and Harel Insurance & Finance Group.